M&A
-
3 highlights from EY’s report on 2026 medtech trends
M&A rose, but company valuations declined in the first half of 2026 compared with the year-ago period, according to EY’s Pulse of the Industry report.
By Elise Reuter • Oct. 29, 2026 -
RadNet expands into teleradiology with $350M Onrad deal
The acquisition, which will give RadNet a new professional services unit, is expected to help hospitals solve challenges with radiology coverage.
By Nick Paul Taylor • Oct. 28, 2026 -
Stryker completes ZuriMED takeover
The deal expands Stryker’s portfolio of fast-growing sports medicine and shoulder care devices.
By Nick Paul Taylor • Oct. 27, 2026 -
Labcorp inks Millennium Health buyout to add drug testing services
The proposed acquisition of the specialty laboratory is the third Labcorp buyout announced in eight days.
By Nick Paul Taylor • Oct. 26, 2026 -
Qiagen agrees to private equity takeover
EQT Private Equity has agreed to pay about $12.1 billion, including debt, for the diagnostics company, which has long been the subject of takeover speculation.
By Susan Kelly • Oct. 23, 2026 -
Labcorp to buy Myriad’s prenatal health testing unit for $210M
Buying the Myriad assets will expand Labcorp’s portfolio of specialty tests for women’s health.
By Nick Paul Taylor • Oct. 22, 2026 -
Abbott plans to spin out its nutrition business
Abbott, which also cut its 2026 sales growth guidance, said company sales will total $42 billion following the separation.
By Ricky Zipp • Oct. 21, 2026 -
The MedTech Conference 2026
Expect more tuck-in M&A, portfolio pruning in medtech, execs say
As medical device makers face “finite” capital, portfolio reshaping will likely remain a focus in the sector.
By Susan Kelly • Oct. 21, 2026 -
Labcorp to buy BioReference assets for up to $872M
Labcorp will pick up specialty testing in women’s health as well as a blood test that assesses the likelihood of finding aggressive prostate cancer before a biopsy decision.
By Susan Kelly • Oct. 15, 2026 -
Agilent to buy Proscia for $240M
The digital pathology firm “fits in very well” with Agilent and moves the company into a sector targeted by Roche, analysts said.
By Nick Paul Taylor • Oct. 14, 2026 -
Steris inks $2.1B Xodus buyout to expand consumables portfolio
The takeover adds high-growth, high-margin products to Steris’ portfolio, analysts said.
By Nick Paul Taylor • Oct. 13, 2026 -
GE HealthCare to acquire Sofie Biosciences for $945M
Sofie Biosciences is expected to expand GE HealthCare’s footprint in the radiopharmaceutical industry, helping manufacture and distribute time-sensitive drugs used in PET imaging.
By Susan Kelly • Oct. 5, 2026 -
J&J sells Laminar LAA closure assets it bought 3 years ago
The decision is part of J&J’s strategy to prioritize resources for the greatest impact and positions Laminar for success under dedicated ownership, a spokesperson said.
By Susan Kelly • Sept. 16, 2026 -
Medtronic begins final steps to separate MiniMed
The separation will allow Medtronic to focus on its cardiovascular, neuroscience and surgical portfolios, CEO Geoff Martha said.
By Elise Reuter • Sept. 14, 2026 -
Axogen to buy BioCircuit Technologies for $200M
Analysts called the acquisition a good fit for Axogen but said the company’s plans to finance the deal with a public stock offering could be a point of contention for investors.
By Susan Kelly • Sept. 10, 2026 -
Labcorp acquires MLM Medical Labs in global expansion
Buying MLM gives Labcorp a wholly owned laboratory network that spans North America, Europe, Asia and Africa.
By Nick Paul Taylor • Sept. 9, 2026 -
Enovis inks eCential takeover to develop surgical ortho robots
The orthopedics specialist aims to launch a knee robot in late 2028, followed by a shoulder robot in 2029.
By Nick Paul Taylor • Sept. 2, 2026 -
Stryker to add rotator cuff repair tech with ZuriMED buy
Rotator cuff augmentation is one of the fastest-growing areas in sports medicine, according to Stryker.
By Elise Reuter • Sept. 1, 2026 -
AMS secures shareholder support for planned sale to H.B. Fuller
Buying tissue-healing company AMS will bring H.B. Fuller into the markets for formulated biosurgicals and mechanical closures.
By Nick Paul Taylor • Updated Aug. 14, 2026 -
Thermo Fisher closes $1.1B sale of microbiology unit to PE firm
European private equity firm Astorg will run the business as an independent diagnostics company, led by former PerkinElmer CEO Dirk Bontridder.
By Susan Kelly • Aug. 13, 2026 -
Teledyne inks $1.1B takeover of Varex Imaging
Buying Varex will increase Teledyne’s exposure to the healthcare market. Teledyne said the companies’ imaging technologies complement each other with minimal overlap.
By Nick Paul Taylor • Aug. 11, 2026 -
IRhythm grows heart monitoring leadership with $288M VitalConnect buy
Acquiring VitalConnect could unlock a $1 billion cardiac monitoring market that is only partly served by iRhythm’s existing devices.
By Nick Paul Taylor • Aug. 10, 2026 -
Retrieved from Integer Holdings on August 03, 2026
KKR to take Integer private for $5.7B
Integer expects to gain flexibility and capital to invest in its contract development and manufacturing business under KKR.
By Elise Reuter • Aug. 3, 2026 -
Cardinal inks 2 acquisitions in bid to expand at-home services
The company agreed to buy a diabetes health business and medical supplier Strive Medical to boost its growing in-home solutions unit.
By Sydney Halleman • July 22, 2026 -
Tempus to buy cancer test maker Personalis for $1.5B
Tempus AI’s planned acquisition follows recent interest in blood-based cancer tests across the medtech industry.
By Elise Reuter • July 20, 2026